Evidence map›Paper›PMID 9806899›Full record

ArticleThe Biochemical journal1998

cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1).

E S Silverman, J Du, A J Williams, R Wadgaonkar, J M Drazen, T Collins

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 120 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Imaging methods to monitor and quantify cell differentiation.Frontiers in cell and developmental biology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E S SilvermanVascular Research Division, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.
J Du
A J Williams
R Wadgaonkar
J M Drazen
T Collins
Brigham and Women's Hospital · US

Funding

Role of PGE2 in Human Mast Cell BiologyP01HL036110 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 1985 to 2009
$20.1M
TRANSCRIPTIONAL REGULATION OF PDGF BY ENDOTHELIUMR37HL035716 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI COLLINS, TUCKER O · 1996 to 2005
$1.9M
Transcriptional Regulation of PDGF by EndotheliumR01HL035716 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FLEMING, MARK D. · 1985 to 2007
$394k
PDGF IN HYPOXIA ASSOCIATED PULMONARY VASCULAR REMODELINGF32HL009613 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, ERIC S · 1996 to 1997
–
NHLBI NIH HHS HL09613NHLBI NIH HHS HL35716NHLBI NIH HHS P01 HL36110
6 · The paper itself

Abstract

Egr-1 (early-growth response factor-1) is a sequence-specific transcription factor that plays a regulatory role in the expression of many genes important for cell growth, development and the pathogenesis of disease. The transcriptional co-activators CBP (cAMP-response-element-binding-protein-binding protein) and p300 interact with sequence-specific transcription factors as well as components of the basal transcription machinery to facilitate RNA polymerase II recruitment and transcriptional initiation. Here we demonstrate a unique way in which Egr-1 physically and functionally interacts with CBP/p300 to modulate gene transcription. CBP/p300 potentiated Egr-1 mediated expression of 5-lipoxygenase (5-LO) promoter-reporter constructs, and the degree of trans-activation was proportional to the number of Egr-1 consensus binding sites present in wild-type and naturally occurring mutants of the 5-LO promoter. The N- and C-terminal domains of CBP interact with the transcriptional activation domain of Egr-1, as demonstrated by a mammalian two-hybrid assay. Direct protein-protein interactions between CBP/p300 and Egr-1 were demonstrated by glutathione S-transferase fusion-protein binding and co-immunoprecipitation/Western-blot studies. These data suggest that CBP and p300 act as transcriptional co-activators for Egr-1-mediated gene expression and that variations between individuals in such co-activation could serve as a genetic basis for variability in gene expression.

Indexed as

AnimalsCOS CellsDNA-Binding ProteinsNuclear ProteinsPrecipitin TestsProtein BindingRecombinant Fusion ProteinsTrans-ActivatorsTranscription FactorsTranscription, GeneticDNA-Binding ProteinsNuclear ProteinsRecombinant Fusion ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID9806899
PMCPMC1219856
OpenAlexW1848987069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.